Veterinary Medicine Information website

COLOMBOVAC PMV/POX

Not authorised
  • Newcastle disease virus, strain La Sota, Inactivated
  • Pigeonpox virus, strain DD, Live

Product identification

Medicine name:
COLOMBOVAC PMV/POX
Active substance:
  • Newcastle disease virus, strain La Sota, Inactivated
  • Pigeonpox virus, strain DD, Live
Target species:
  • Pigeon
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Newcastle disease virus, strain La Sota, Inactivated
    109.00
    50% Embryo Infective Dose
    /
    1.00
    Dose
  • Pigeonpox virus, strain DD, Live
    103.50
    50% tissue culture infectious dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate and suspension for suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Pigeon
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01EH01
Authorisation status:
  • Surrendered
Authorised in:
  • Spain
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Zoetis Spain S.L.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Manufacturing & Research Spain S.L.
  • Zoetis Manufacturing & Research Spain S.L.
Responsible authority:
  • Spanish Agency For Medicines And Health Products
Authorisation number:
  • 1327 ESP
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 8/11/2022

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 8/11/2022

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 8/11/2022